Recombinant antigen EBNA1 for Epstein-barr virus

Ask for quotation or Call me back

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

View more information about Epstein-Barr virus infection.

REFERENCES

RAG0007

WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA

GENE

BKRF1

DESCRIPTION

Late nuclear antigen

PURITY

>95% in a SDS-PAGE

SHIPPING AND STORAGE CONDITIONS

Proteins will be shipped on dry ice or ice pack. Upon arrival they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles

STABILITY

The protein will remain stable for four years if stored frozen

SPECIFICITY

The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection

IVD

Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals

SATISFACTION GUARANTEE

83% success rate in evaluations of recombinant antigen EBNA1 (RAG0007) for the development of a diagnostic assay

EVALUATION

View Details

PROMOTIONAL MATERIAL

Catalogue
Rekom EBV high quality raw material
Success rate of Rekom Biotech best sellers
Recombinant antigen EBNA1 for Epstein-barr virus